Research
Search
Close
GU Jiemei
- Graduate Supervisor, Associate Chief Physician
- Department: Endocrinology and Metabolism
- Research Area: Internal Medicine (Endocrinology and Metabolism)
- Research Interests: metabolic bone disease
- Contact: gujiemei81@163.com
- MD from Shanghai Jiao Tong University School of Medicine, 2018
- Master of Medicine from Shanghai Jiao Tong University School of Medicine, 2007 (7-year Undergraduate and Master's Program）
- Associate chief physician, Department of Osteoporosis and Bone Diseases, Shanghai Sixth People's Hospital
- Jiemei Gu, Hao Zhang, Qingyun Xue et al. Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III study. Journal of Orthopaedic Translation. 29;38:117-125. 2022. doi: 10.1016/j.jot.2022.06.007.
- Jiemei Gu, Hua Yue, Chun Wang et al. Vitamin D pathway gene variation rs3740165 is associated with serological uric acid levels in healthy Chinese women. Frontiers in Endocrinology. 13;13:1059964. 2022. doi: 10.3389/fendo.2022.1059964.
- Hao Zhang, Jie-Mei Gu, Ai-Jun Chao et al. A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk. Acta Pharmacologica Sinica. 44(2):446-453. 2023. doi: 10.1038/s41401-022-00954-y.
- Jiemei Gu, Chun Wang, Hao Zhang, et al. No association between the vitamin D pathway gene polymorphisms and bone biomarkers response to calcium and low dose calcitriol supplementation in postmenopausal Chinese women: a one-year prospective study. BIOMARKERS. 23(7):664-669.2018. doi: 10.1080/1354750X.2018.1474259.
- Gu J, Wang C, Zhang H,et al. Targeted resequencing of phosphorus metabolism related genes in 86 patients with hypophosphatemic rickets/osteomalacia. Int J Mol Med. 42(3):1603-1614.2018. doi: 10.3892/ijmm.2018.3730.
- Gu JM, Wang L, Lin H, et al. The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data. Acta Pharmacol Sin. 36(7):841-6.2015. doi: 10.1038/aps.2015.30.
- Jie-Mei Gu, Yao-Hua Ke, Hua Yue et al. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family. Bone. 52(1):9-16. 2013. doi: 10.1016/j.bone.2012.09.012.
- Gu JM, Hu YQ, Zhang H, et al. A mutation in NOTCH2 gene in a Chinese patient with Hajdu-Cheney syndrome. Joint Bone Spine. 80(5):548-9.2013. doi: 10.1016/j.jbspin.2013.02.008.
- Gu JM, Zhang ZL, Zhang H et al. Thirteen Chinese patients with sporadic Paget's disease of bone: clinical features, SQSTM1 mutation identification, and functional analysis. J Bone Miner Metab. 30(5):525-33. 2012. doi: 10.1007/s00774-012-0352-6.
- Gu JM, Xiao WJ, He JW, et al. Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families. Acta Pharmacol Sin . 30(12):1634-42.2009. doi: 10.1038/aps.2009.169.
